Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors - Doerffel, Y.; Kullmann, F.; Lammert, F.; Quietzsch, D.; Schöfl, Christof; Schuppert, F.; Weber, M.; Baum, V.; Berndt, I.; Weiss, C.; Lahner, H. (2017)
EVALuna2:33894